Featured Research

from universities, journals, and other organizations

New Kind Of Drug Could Increase Number Who Quit Smoking

Date:
May 3, 2006
Source:
Blackwell Publishing Ltd.
Summary:
Smokers are twice as likely to quit if they use medication, but 80% will be smoking again within a year. These success rates could be improved with a new kind of drug currently being evaluated by the FDA under a six-month priority review, according to a leading smoking research centre.

Smokers who try to quit using existing medications, such as nicotine patches or Zyban, are about twice as likely to succeed as those who don't use medication or are prescribed placebos during clinical trials.

Related Articles


But despite the relative effectiveness of medications currently on the market, more than 80 per cent of quitters will be smoking again within a year, according to a review in the latest IJCP, the UK-based International Journal of Clinical Practice.

A new kind of drug has now been developed that could improve long-term quit rates, according to Dr Jonathan Foulds from the Tobacco Dependence Program at the University of Medicine and Dentistry of New Jersey.

Varenicline is being evaluated by the US Food and Drug Administration under a six-month priority review which began in late 2005.

"Trials carried out so far have yielded promising results, suggesting that varenicline could be a major advance in the treatment of nicotine dependence" says Dr Foulds.

"Drugs are normally earmarked for priority review by the FDA if they are felt to address health needs that are not currently being adequately met.

"What makes varenicline different to existing medication is that it is the first treatment specifically designed to target the neurobiological mechanism of nicotine dependence."

Initial results show that the drug successfully stimulates dopamine -- sometimes called the brain's pleasure chemical -- as well as blocking nicotine receptors. This reduces nicotine withdrawal symptoms and craving and may also prevent a lapse from turning into a full relapse.

Existing quit smoking methods have limited success and studies have found that some 18 per cent of people using them will be smoke free after a year, compared with 10 per cent of people prescribed placebos.

This figure can be increased to 25 to 35 per cent when smokers receive intensive counselling and combined medications are used.

Dr Foulds summarised 141 studies covering just over 48,000 subjects who were randomly allocated different types of medication or placebos.

He found that quit rates with nicotine replacement methods and drugs such as bupropion (trade name Zyban), nortriptyline and clonidine ranged from 14.6 per cent to 24.9 per cent. Smokers who were prescribed placebos (dummy drugs) achieved success rate of between 8.6 per cent and 14.4 per cent.

But clinical trials carried out with varenicline on thousands of smokers suggest that the new drug yield may yield better success rates.

The results of human trials reported in 2005 and 2006 found that short and long-term quit rates were higher when compared with placebos or bupropion (Zyban).

Studies presented at recent scientific meetings have shown that short-term quit rates in the first 12 weeks were approximately four times higher with varenicline than placebos and that long-term abstinence rates, for the first year, were more than twice those of placebos.

"Almost 20 countries and numerous US states have already announced or implemented comprehensive indoor smoking bans and that figure is rising all the time" adds Dr Foulds.

"Here in New Jersey, for example, smoking is very expensive and we have just implemented comprehensive legislation to ban smoking indoors in virtually all pubic places.

"This is good news for smokers and non smokers alike as many smokers are keen to quit and this gives them an added incentive.

"Medicines like varenicline are very important as they will help many more people to quit smoking, including those who have failed with other methods."


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "New Kind Of Drug Could Increase Number Who Quit Smoking." ScienceDaily. ScienceDaily, 3 May 2006. <www.sciencedaily.com/releases/2006/05/060503100419.htm>.
Blackwell Publishing Ltd.. (2006, May 3). New Kind Of Drug Could Increase Number Who Quit Smoking. ScienceDaily. Retrieved January 26, 2015 from www.sciencedaily.com/releases/2006/05/060503100419.htm
Blackwell Publishing Ltd.. "New Kind Of Drug Could Increase Number Who Quit Smoking." ScienceDaily. www.sciencedaily.com/releases/2006/05/060503100419.htm (accessed January 26, 2015).

Share This


More From ScienceDaily



More Mind & Brain News

Monday, January 26, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Technology Is Ruining Snow Days For Students

How Technology Is Ruining Snow Days For Students

Newsy (Jan. 25, 2015) — More schools are using online classes to keep from losing time to snow days, but it only works if students have Internet access at home. Video provided by Newsy
Powered by NewsLook.com
Weird Things Couples Do When They Lose Their Phone

Weird Things Couples Do When They Lose Their Phone

BuzzFeed (Jan. 24, 2015) — Did you back it up? Do you even know how to do that? Video provided by BuzzFeed
Powered by NewsLook.com
Smart Wristband to Shock Away Bad Habits

Smart Wristband to Shock Away Bad Habits

Reuters - Innovations Video Online (Jan. 23, 2015) — A Boston start-up is developing a wristband they say will help users break bad habits by jolting them with an electric shock. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com
Amazing Technology Allows Blind Mother to See Her Newborn Son

Amazing Technology Allows Blind Mother to See Her Newborn Son

RightThisMinute (Jan. 23, 2015) — Not only is Kathy seeing her newborn son for the first time, but this is actually the first time she has ever seen a baby. Kathy and her sister, Yvonne, have been legally blind since childhood, but thanks to an amazing new technology, eSight glasses, which gives those who are legally blind the ability to see, she got the chance to see the birth of her son. It&apos;s an incredible moment and an even better story. Video provided by RightThisMinute
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins